Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
Breast Cancer Research and Treatment
|
September 16, 2021
The WISDOM study: a new approach to screening can and should be tested
Laura Esserman, Martin Eklund, Laura Van't Veer, et al.
JAMA
|
May 12, 2011
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer
Christos Hatzis, Lajos Pusztai, Vicente Valero, et al.
Lancet (London, England)
|
November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Jayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Nature Biotechnology
|
February 5, 2025
Implantation of engineered adipocytes suppresses tumor progression in cancer models
Hai P Nguyen, Kelly An, Yusuke Ito, et al.
Research Square
|
February 23, 2026
Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trial
Amrita Basu, Saumya Umashankar, Michelle Melisko, et al.
JCO Precision Oncology
|
June 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial
Denise M Wolf, Christina Yau, Michael Campbell, et al.
Human Genetics
|
February 28, 2019
A response to "Personalised medicine and population health: breast and ovarian cancer"
Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development
Douglas Yee, Tufia Haddad, Kathy Albain, et al.
Research Square
|
November 19, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design
Allison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
Breast Cancer Research and Treatment
|
September 16, 2021
The WISDOM study: a new approach to screening can and should be tested
Laura Esserman, Martin Eklund, Laura Van't Veer, et al.
JAMA
|
May 12, 2011
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer
Christos Hatzis, Lajos Pusztai, Vicente Valero, et al.
Lancet (London, England)
|
November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Jayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Nature Biotechnology
|
February 5, 2025
Implantation of engineered adipocytes suppresses tumor progression in cancer models
Hai P Nguyen, Kelly An, Yusuke Ito, et al.
Research Square
|
February 23, 2026
Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trial
Amrita Basu, Saumya Umashankar, Michelle Melisko, et al.
JCO Precision Oncology
|
June 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial
Denise M Wolf, Christina Yau, Michael Campbell, et al.
Human Genetics
|
February 28, 2019
A response to "Personalised medicine and population health: breast and ovarian cancer"
Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development
Douglas Yee, Tufia Haddad, Kathy Albain, et al.
Research Square
|
November 19, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design
Allison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
Page
of 15